BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21755480)

  • 1. [PIBF - Progesterone-Induced Blocking Factor].
    Ermisch C; Markert UR
    Z Geburtshilfe Neonatol; 2011 Jun; 215(3):93-7. PubMed ID: 21755480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions.
    Szekeres-Bartho J; Šućurović S; Mulac-Jeričević B
    Front Immunol; 2018; 9():2890. PubMed ID: 30619262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of a novel monoclonal antibody against progesterone-induced blocking factor (PIBF).
    Ivanova-Todorova E; Kyurkchiev DS; Nalbanski A; Timeva T; Shterev A; Kyurkchiev SD
    J Reprod Immunol; 2008 Jul; 78(2):94-101. PubMed ID: 18243332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
    Raghupathy R; Al-Mutawa E; Al-Azemi M; Makhseed M; Azizieh F; Szekeres-Bartho J
    J Reprod Immunol; 2009 Jun; 80(1-2):91-9. PubMed ID: 19371956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologia futura: embryo-maternal communication via progesterone-induced blocking factor (PIBF) positive embryo-derived extracellular vesicles. Their role in maternal immunomodulation.
    Szekeres-Bartho J; Csabai T; Gorgey E
    Biol Futur; 2021 Mar; 72(1):69-74. PubMed ID: 34554496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness.
    Miko E; Halasz M; Jericevic-Mulac B; Wicherek L; Arck P; Arató G; Skret Magierlo J; Rukavina D; Szekeres-Bartho J
    J Reprod Immunol; 2011 Jun; 90(1):50-7. PubMed ID: 21632119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIBF: the double edged sword. Pregnancy and tumor.
    Szekeres-Bartho J; Polgar B
    Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human trophoblast cells express the immunomodulator progesterone-induced blocking factor.
    Anderle C; Hammer A; Polgár B; Hartmann M; Wintersteiger R; Blaschitz A; Dohr G; Desoye G; Szekeres-Barthó J; Sedlmayr P
    J Reprod Immunol; 2008 Oct; 79(1):26-36. PubMed ID: 18817979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
    Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
    Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A progesterone-induced protein increases the synthesis of asymmetric antibodies.
    Kelemen K; Bognar I; Paal M; Szekeres-Bartho J
    Cell Immunol; 1996 Jan; 167(1):129-34. PubMed ID: 8548836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone-induced blocking factor inhibits degranulation of natural killer cells.
    Faust Z; Laskarin G; Rukavina D; Szekeres-Bartho J
    Am J Reprod Immunol; 1999 Aug; 42(2):71-5. PubMed ID: 10476687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes.
    Szekeres-Bartho J; Faust Z; Varga P
    Am J Reprod Immunol; 1995 Dec; 34(6):342-8. PubMed ID: 8607938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of macrophages in utero-placental interactions during normal and pathological pregnancy.
    Renaud SJ; Graham CH
    Immunol Invest; 2008; 37(5):535-64. PubMed ID: 18716937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and the immunology of pregnancy.
    Druckmann R; Druckmann MA
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):389-96. PubMed ID: 16198558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion.
    Liang Q; Tong L; Xiang L; Shen S; Pan C; Liu C; Zhang H
    Clin Exp Immunol; 2021 Jan; 203(1):55-65. PubMed ID: 33017473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome.
    Polgár B; Nagy E; Mikó E; Varga P; Szekeres-Barthó J
    Biol Reprod; 2004 Nov; 71(5):1699-705. PubMed ID: 15269099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor.
    Polgar B; Kispal G; Lachmann M; Paar C; Nagy E; Csere P; Miko E; Szereday L; Varga P; Szekeres-Bartho J
    J Immunol; 2003 Dec; 171(11):5956-63. PubMed ID: 14634107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein.
    Check JH; Dix E; Sansoucie L
    Med Hypotheses; 2009 Jan; 72(1):87-90. PubMed ID: 18842348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production by lymphocytes in pregnancy.
    Szereday L; Varga P; Szekeres-Bartho J
    Am J Reprod Immunol; 1997 Dec; 38(6):418-22. PubMed ID: 9412725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.